Refine by
Surgery Product Articles & Analysis
69 news found
Synaptive Medical has received $900,000 in support from the Ontario government through the Ontario Together Fund. This funding will support Synaptive Medical’s $2.8 million project to expand manufacturing and research and development activities related to the company’s head-only Magnetic Resonance Imaging (MRI) system. The Synaptive MRI is a 0.5T system that was designed to overcome ...
Caira Surgical, the pioneer in radar surgical tracking for navigated and robotic joint replacement surgery, announced today that Jon Greenwald, Chief Executive Officer, and Irina Benimovich, Chief Financial Officer, will conduct investor meetings and host presentations at the upcoming CG 2023 Musculoskeletal Conference and LSI USA '23 partnering event. ...
(FREMONT, CA) November 14, 2022 – THINK Surgical, a technology innovator developing orthopedic surgical robots, today announced the implementation of a new, experienced commercial leadership team. Following a recent successful financing round which will enable accelerated commercialization of several new products, THINK Surgical is excited to introduce the leadership team who will lead ...
(FREMONT, CA) October 26, 2022 – THINK Surgical, a technology innovator developing orthopedic surgical robots today announced that KDB Investment Global Healthcare of Korea, a new investor, has invested $100M in the company to enable a faster commercial launch of several new products. This investment will allow THINK Surgical to bring new products to ...
McKinsey’s Values and Value event series convenes ESG leaders from across the Life Sciences industry to discuss the hot topics, questions, wins, and challenges that arise on the path to improving the industry’s environmental and social impact. During the session, Rob Chase, Founder and President of NewGen Surgical, and Samantha Smith, Director at Medtronic’s Sustainability ...
NewGen Surgical Inc. announced today that it has earned the U.S. Department of Agriculture (USDA) Certified Biobased Product label on all product lines. Managed by the U.S. Department of Agriculture (USDA), the BioPreferred Program is an initiative created by the 2002 Farm Bill (and recently reauthorized by the 2018 Farm Bill), to increase the development, purchase, and use of biobased products. ...
Caldera Medical, a medical device company that develops best-in-class surgical products for the treatment of Stress Urinary Incontinence, Pelvic Organ Prolapse, and Polyps announced the launch of Desara® TVez, an expansion to their Desara® Family of products. “Staying true to our commitment of being surgeon and patient focused, Caldera Medical collaborated with dozens of leading ...
Supported by the Scottish Development Agency, the Scottish-based medical device company were amongst the 4,250 other companies exhibiting at the show, where they were showcasing their revolutionary product OpLight™ – a single use, sterile, LED surgical light. Designed to directly illuminate the interior cavity of an incision during surgery, the ...
Fronk will be responsible for defining the user needs for products in development as well as building a sales and marketing organization ahead of important new product introductions in both the US market and elsewhere around the world. ...
Acumed, a Colson Medical - Marmon - Berkshire Hathaway company, is excited to announce the acquisition of ExsoMed, a provider of innovative solutions for hand surgery. The addition of ExsoMed, whose products support an intramedullary approach to treating hand fractures, enhances Acumed’s comprehensive portfolio of upper extremity solutions for simple to ...
Food & Drug Administration (“FDA”) to market its first product, a fluorescence guided surgery (FGS) system. The OnLume Imaging System is indicated for fluorescence imaging of blood flow and tissue perfusion before, during, and after vascular, gastrointestinal, organ transplant, plastic, reconstructive, and micro surgeries. This ...
Surgical has signed the Department of Health and Human Services (HHS) climate pledge initiative NewGen in partnership with the White House to mobilize the healthcare sector to reduce carbon emissions. On April 22, 2022, the HHS issued a call to action for healthcare stakeholders to commit to tackling the climate crisis through a new initiative aimed at reducing emissions across the healthcare ...
SANUWAVE Health, Inc. (OTCQB:SNWV), a leading provider of next-generation wound care products and its JV partner Diversa S.A. have announced a new distribution agreement with Grupo Suprimed to market and sell the dermaPACE® System in the private healthcare market in Brazil. The dermaPACE® System is currently licensed or approved for advanced wound care indications in Brazil, Mexico and ...
Flowonix Medical and Miratech Medical today announced the acquisition of the U.S. distribution rights to Flowonix’s state-of-the-art targeted drug delivery system for the treatment of chronic pain and spasticity by Miratech Medical in a transaction that closed on May 11th. Miratech has long served as the exclusive agent for Flowonix products for certain markets, primarily in the Midwest. ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces its participation in two upcoming investor conferences. ...
CytoSorbents will now directly commercialize its products in 15 countries, with sales in more than 70 countries worldwide. ...
About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using blood purification. Its flagship product, CytoSorb®, is approved in the European Union with distribution in more than 70 countries around the world as an extracorporeal cytokine ...
Isto Biologics, a leader in surgical-based, orthobiologic regeneration technologies and cell-based therapies, announced today that it has acquired TheraCell, Inc., a California-based regenerative medicine company. The acquisition will strengthen Isto’s focus on offering extraordinary solutions for surgical and clinical care procedures within spine, orthopedics, and sports medicine. ...
CYNK-101 for the Treatment of HER2+ Gastric Cancer: CYNK-101 is a novel allogeneic off-the-shelf human placental CD34+-derived NK cell product candidate that is genetically modified to express high-affinity and cleavage-resistant CD16 (FCGRIIIA) variant to drive antibody-dependent cell-mediated cytotoxicity. ...
” The Versius® Surgical Robotic System Versius® resets expectations of robotic surgery. Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). ...